^
    Back
    Association details:
    Biomarker:ABCG2 overexpression
    Cancer:Head and Neck Cancer
    Drug:paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter)
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: C3 – Early Trials
    New
    Source:
    Mol Biol Rep
    Title:

    Differential expression of ABCB1, ABCG2, and KLF4 as putative indicators for paclitaxel resistance in human epithelial type 2 cells

    Published date:
    01/28/2021
    Excerpt:
    Our findings suggest that higher expressions of ABCB1, ABCG2, and KLF4 might be considered as putative indicators for paclitaxel resistance in LSCC patients.
    DOI:
    10.1007/s11033-021-06167-6